EQL Pharma AB (EQL.ST) released earnings for second quarter that Drops, from last year
The company's bottom line came in at SEK9.82 million, or SEK0.33 per share. This compares with SEK10.41 million, or SEK0.36 per share, last year.
The company's revenue for the period rose 29.5% to SEK107.21 million from SEK82.78 million last year.
EQL Pharma AB earnings at a glance (GAAP) :
-Earnings: SEK9.82 Mln. vs. SEK10.41 Mln. last year.-EPS: SEK0.33 vs. SEK0.36 last year.-Revenue: SEK107.21 Mln vs. SEK82.78 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.